Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intravitreal avastin: the low cost alternative to lucentis?

× No keyword cloud information.

25 in total

1. The effect of glutathione as chain transfer agent in PNIPAAm-based thermo-responsive hydrogels for controlled release of proteins.

Authors: Pawel W Drapala; Bin Jiang; Yu-Chieh Chiu; William F Mieler; Eric M Brey; Jennifer J Kang-Mieler; Victor H Pérez-Luna
Journal: Pharm Res Date: 2014-03 Impact factor: 4.200

Review 2. Age-related macular degeneration and recent developments: new hope for old eyes?

Authors: Brid Morris; Fraser Imrie; Ana-Maria Armbrecht; Baljean Dhillon
Journal: Postgrad Med J Date: 2007-05 Impact factor: 2.401

3. [Compliance of age related macular degeneration patients undergoing anti-VEGF therapy : Analysis and suggestions for improvement].

Authors: B Heimes; F Gunnemann; M Ziegler; M Gutfleisch; G Spital; D Pauleikhoff; A Lommatzsch
Journal: Ophthalmologe Date: 2016-11 Impact factor: 1.059

4. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model.

Authors: Timothy W Olsen; Xiao Feng; Kathy Wabner; Karl Csaky; Stefan Pambuccian; J Douglas Cameron
Journal: Invest Ophthalmol Vis Sci Date: 2011-07-01 Impact factor: 4.799

5. Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.

Authors: Carolyn K Pan; Chandrasekar Durairaj; Uday B Kompella; Ogechi Agwu; Scott C N Oliver; Hugo Quiroz-Mercado; Naresh Mandava; Jeffrey L Olson
Journal: J Ocul Pharmacol Ther Date: 2011-05-16 Impact factor: 2.671

6. UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice.

Authors: Aaron Y Lee; Cecilia S Lee; Catherine A Egan; Clare Bailey; Robert L Johnston; Salim Natha; Robin Hamilton; Rehna Khan; Sahar Al-Husainy; Christopher Brand; Toks Akerele; Martin Mckibbin; Louise Downey; Adnan Tufail
Journal: Br J Ophthalmol Date: 2017-05-06 Impact factor: 4.638

7. Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration.

Authors: Mamdouh M Kabeel; Ashraf M El-Batarny; Mohamed K Tameesh; Moustafa A Abou El Enein
Journal: Clin Ophthalmol Date: 2008-03

8. Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity.

Authors: Beatrix Feigl; Amanda Greaves; Brian Brown
Journal: Clin Ophthalmol Date: 2007-06

9. Diabetic retinopathy - An update.

Authors: Abdulrahman A Alghadyan
Journal: Saudi J Ophthalmol Date: 2011-01-31

Review 10. Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy.

Authors: R Simó; C Hernández
Journal: Diabetologia Date: 2008-04-11 Impact factor: 10.122